Significance and Use
This practice is intended to help assess the biocompatibility of materials used in medical devices. It is an acute toxicological test designed to detect the presence of injurious leachable substances.
This practice may not be appropriate for all types of implant applications. The user is cautioned to consider the appropriateness of the method in view of the materials being tested, their potential applications, and the recommendations contained in Practice F 748.
The only limitation applicable is the extract preparation. Refer to Sections 4.3 and 4.4 of Practice F 619 for a description of this limitation.
1. Scope
1.1 This practice covers a nonspecific, acute toxicity test used for detecting leachables from materials used in medical devices.
1.2 The liquids injected into the mouse are those obtained by Practice F 619 where the extraction vehicles are saline, vegetable oil, or other liquids simulating human body fluids.
1.3 Two procedures are outlined: Method A for intravenous injection and Method B for intraperitoneal injection.
1.4 This practice is one of several developed for the assessment of the biocompatibility of materials. Practice F 748 may provide guidance for the selection of appropriate methods for testing materials for a specific application.
2. Referenced Documents (purchase separately)
The documents listed below are referenced within the subject standard but are not provided as part of the standard.
ASTM Standards
F619 Practice for Extraction of Medical Plastics
F748 Practice for Selecting Generic Biological Test Methods for Materials and Devices
Index Terms
acute toxicity tests; biocompatibility; intravenous injection; intraperitoneal injections; mouse/mice; test animals;
ICS Code
ICS Number Code 11.220 (Veterinary medicine)
DOI: 10.1520/F0750-87R07E01
ASTM International is a member of CrossRef.
Citing ASTM Standards
[Back to Top]